Literature DB >> 2063895

Cognitive profiles associated with the fra(X) syndrome in males and females.

L S Freund1, A L Reiss.   

Abstract

Twenty-three fragile X [fra(X)] males (mean IQ 50, mean age 10 years) and 11 fra(X) females (mean IQ 84, mean age 11.3 years) were administered the Stanford-Binet Intelligence Scale, 4th ed. (S-B). The cognitive profiles generated from the S-B indicated a pattern of subtest strengths and weaknesses that was similar for both groups. Consistent weaknesses in both groups were found in quantitative skills and short-term memory recall for visually presented, abstract stimuli, whereas a consistent strength was observed for short-term memory recall of visually presented, meaningful stimuli. Strengths in verbal labeling and comprehension and deficits in spatial visualization and visual-motor coordination were identified by the S-B for the male group but not for the female group. Fragility in the female group was negatively correlated with the S-B score for the short-term memory area and the combined S-B scores for the verbal reasoning and quantitative reasoning areas. The specific, S-B-identified cognitive strengths and weaknesses associated with the fra(X) condition are potentially useful indicators for investigation of specific cognitive process deficits associated with the fra(X) condition and the design of appropriate educational interventions for fra(X) children.

Entities:  

Mesh:

Year:  1991        PMID: 2063895     DOI: 10.1002/ajmg.1320380409

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  48 in total

1.  Discrimination learning and attentional set formation in a mouse model of Fragile X.

Authors:  Kimberly S Casten; Annette C Gray; Rebecca D Burwell
Journal:  Behav Neurosci       Date:  2011-06       Impact factor: 1.912

2.  Examining the neural correlates of emergent equivalence relations in fragile X syndrome.

Authors:  Megan Klabunde; Manish Saggar; Kristin M Hustyi; Ryan G Kelley; Allan L Reiss; Scott S Hall
Journal:  Psychiatry Res       Date:  2015-06-30       Impact factor: 3.222

Review 3.  Moving Toward Integrative, Multidimensional Research in Modern Psychiatry: Lessons Learned From Fragile X Syndrome.

Authors:  Lawrence K Fung; Allan L Reiss
Journal:  Biol Psychiatry       Date:  2015-12-18       Impact factor: 13.382

Review 4.  Insights into brain development from neurogenetic syndromes: evidence from fragile X syndrome, Williams syndrome, Turner syndrome and velocardiofacial syndrome.

Authors:  E Walter; P K Mazaika; A L Reiss
Journal:  Neuroscience       Date:  2009-04-17       Impact factor: 3.590

5.  Visuospatial and numerical cognitive deficits in children with chromosome 22q11.2 deletion syndrome.

Authors:  Tony J Simon; Carrie E Bearden; Donna McDonald Mc-Ginn; Elaine Zackai
Journal:  Cortex       Date:  2005-04       Impact factor: 4.027

6.  Neuroanatomical abnormalities in fragile X syndrome during the adolescent and young adult years.

Authors:  Gisela M Sandoval; Sehoon Shim; David S Hong; Amy S Garrett; Eve-Marie Quintin; Matthew J Marzelli; Swetapadma Patnaik; Amy A Lightbody; Allan L Reiss
Journal:  J Psychiatr Res       Date:  2018-10-25       Impact factor: 4.791

7.  Viewing social scenes: a visual scan-path study comparing fragile X syndrome and Williams syndrome.

Authors:  Tracey A Williams; Melanie A Porter; Robyn Langdon
Journal:  J Autism Dev Disord       Date:  2013-08

8.  Contrast detection in infants with fragile X syndrome.

Authors:  F Farzin; D Whitney; R J Hagerman; S M Rivera
Journal:  Vision Res       Date:  2008-05-23       Impact factor: 1.886

9.  Neurobehavioral effects of the fragile X premutation in adult women: a controlled study.

Authors:  A L Reiss; L Freund; M T Abrams; C Boehm; H Kazazian
Journal:  Am J Hum Genet       Date:  1993-05       Impact factor: 11.025

Review 10.  Oxytocin and vasopressin systems in genetic syndromes and neurodevelopmental disorders.

Authors:  S M Francis; A Sagar; T Levin-Decanini; W Liu; C S Carter; S Jacob
Journal:  Brain Res       Date:  2014-01-22       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.